Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-108847

See remarks sold 6,200 shares at an average $52.93 ($328,164)

  • See remarks acquired 6,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-09-20 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 1 in the form
Goldshleger Ilya See remarks 2024-09-20 Sale 10b5-1 −3,100 $53.19 $164,901 42,246 D: show line 2 in the form
Goldshleger Ilya See remarks 2024-09-23 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 3 in the form
Goldshleger Ilya See remarks 2024-09-23 Sale 10b5-1 −2,950 $52.62 $155,233 42,396 D: show line 4 in the form
Goldshleger Ilya See remarks 2024-09-23 Sale 10b5-1 −150 $53.53 $8,030 42,246 D: show line 5 in the form
Open-market sales · 6,200 sh · avg $52.93 · $328,164

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Goldshleger Ilya See remarks 2024-09-20 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 109,007 D: show line 6 in the form
Goldshleger Ilya See remarks 2024-09-23 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 105,907 D: show line 7 in the form
Loading xslF345X05/ownership.xml…